Systematic review of medical therapy to prevent recurrent diverticulitis

International Journal of Colorectal Disease

Volumn 27, Issue 9, 2012, Pages 1131-1136

  Ünlü, Çagdas ^a   Daniels, Lidewine ^a   Vrouenraets, Bart C ^b   Boermeester, Marja A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Diverticular disease; Medical treatment; Recurrent

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; BACTERIUM LYSATE; BALSALAZIDE; CIPROFLOXACIN; MESALAZINE; PROBIOTIC AGENT; RIFAXIMIN; VSL3;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; BLOATING; DEFECATION HABIT; DIARRHEA; DIVERTICULITIS; ESCHERICHIA COLI; FEVER; HUMAN; PRIORITY JOURNAL; PROTEUS VULGARIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REMISSION; REVIEW; SYSTEMATIC REVIEW;

ANTI-BACTERIAL AGENTS; DIETARY FIBER; DIVERTICULITIS; HUMANS; MESALAMINE; PROBIOTICS; RECURRENCE;

EID: 84866988758     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1486-7     Document Type: Review

References (35)

1. Stollman NH, Raskin JB (1999) Diagnosis and management of diverticular disease of the colon in adults: ad hoc practice parameters committee of the American college of gastroenterology. Am J Gastroenterol 94:3110-3121
2. Colcock BP (1958) Surgical management of complicated diverticulitis. N Engl J Med 259:570-573
3. Parks TG (1969) Natural history of diverticular disease of the colon: a review of 521 cases. Br Med J 4:639-642
4. Rafferty J, Shellito P, Hyman NH et al (2006) Standards Committee of the American Society of Colon and Rectal Surgeons. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 49:939-944
5. Chautems RC, Ambrosetti P, Ludwig A et al (2002) Long term follow-up after first acute episode of sigmoid diverticulitis: is surgery mandatory? Dis Colon Rectum 45:962-966
6. Hjern F, Josephson T, Altmans D et al (2008) Outcome of younger patients with acute diverticulitis. Br J Surg 95:758-764
7. Chapman J, Dozois E, Wolff B et al (2006) Diverticulitis: a progressive disease? Do multiple recurrences predict less favorable outcomes? Ann Surg 243:876-883
8. Hart AR, Kennedy JH, Stebbings WS et al (2000) How frequently do large bowel diverticula perforate? An incidence and crosssectional study. Eur J Gastroenterol Hepatol 12:661-666
9. Richards RJ, Hammitt JK (2002) Timing of prophylactic surgery in prevention of diverticulitis recurrence: a cost-effectiveness analysis. Dig Dis Sci 47:1903-1908
10. Salem L, Veenstra DL, Sullivan SD et al (2004) The timing of elective colectomy in diverticulitis: a decision analysis. J Am Coll Surg 199:904-912
11. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
12. Tursi A, Brandimarte G, Daffina (2002) Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 34:510-5
13. Dughera L, Serra AM, Battaglia E et al (2004) Acute recurrent diverticulitis is prevented by administration of a polybacterial lysate suspension. Minerva Gastroenterol Dietol 50:49-53
14. Tursi A, Brandimarte G, Giorgetti GM et al (2007) Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 22:1103-1108
15. Burkitt DP, Walker AR, Painter NS (1972) Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet 2:1408-1412
16. Hyland JM, Taylor I (1980) Does a high fibre diet prevent the complications of diverticular disease? Br J Surg 67:77-79
17. Kohler L, Sauerland S, Neugebauer E (1999) Diagnosis and treatment of diverticular disease: results of a consensus development conference. Surg Endosc 13:430-436
18. Ludeman L, Warren BF, Shepherd N (2002) The pathology of diverticular disease. Best Pract Res Clin Gastroenterol 16:543-562
19. Sheperd NA (1996) Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades. Gut 38:801-802
20. Rogler G, Andus T (1998) Cytokines in inflammatory bowel disease. World J Surg 22:382-389
21. Tursi A, Brandimarte G, Giorgetti GM et al (2006) Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci 52:671-674
22. Di Mario F, Aragona G, Leandro G et al (2005) Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci 50:581-586
23. Tursi A, Brandimarte G, Giorgetti GM et al (2006) Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol 40:312-316
24. Comparato G, Fanigliulo L, Cavallaro LG et al (2007) Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci 52:2934-2941
25. Tursi A (2004) Diverticular disease of the colon. Lancet 363:1397-1398
26. Floch MH, Bina I (2004) The natural history of diverticulitis: fact and theory. J Clin Gastroenterol 38:S2-S7
27. Frič P, Zavoral M (2003) The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15:313-315
28. Lamiki P, Tsuchiya J, Pathak S et al (2010) Probiotics in Diverticular Disease of the Colon: an Open Label Study. J Gastrointest Liver Dis 19(1):31-6
29. Papi C, Ciaco A, Koch M et al (1992) Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Ital J Gastroenterol 24:452-456
30. Latella G, Pimpo MT, Sottili S et al (2003) Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18:55-62
31. Papi C, Ciaco A, Koch M et al (1995) Diverticular Disease Study Group: Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre doubleblind placebo-controlled trial. Aliment Pharmacol Ther 9:33
32. Porta E, Germano A, Ferrieri A et al (1994) The natural history of diverticular disease of the colon: a rol for antibiotics in preventinbg complications? Eur Rev Med Pharmacol Sci 16:33-39
33. Andeweg CS, Knobben L, Hendriks JC, Bleichrodt RP, van Goor H (2011) How to diagnose acute left-sided colonic diverticulitis: proposal for a clinical scoring system. Ann Surg 253(5):940-6
34. LamerisW, van Randen A, van Gulik TM, Busch OR,Winkelhagen J, Bossuyt PM et al (2010) A clinical decision rule to establish the diagnosis of acute diverticulitis at the emergency department. Dis Colon Rectum 53:896-904
35. Phase III, randomised double blind dose-response stratified placebo controlled study of evaluating the safety and efficacy of SPD476 versus placebo over 104 weeks in the prevention of recurrence of diverticulitis (PREVENT 2). Clinical.Trials. gov.Identifier (http://www.clinicaltrials.gov): NCT00545103. Principal Investigator: Raskin JB, University of Miami Miller School of Medicine, USA